(Q48563473)

12 February 2018

title

Sertraline alters multidrug resistance phosphoglycoprotein activity in the mouse placenta and fetal blood-brain barrier (English)

1 reference

12 February 2018

1 reference

multiple drug resistance

1 reference

1 reference

Manzerul Bhuiyan

1

1 reference

12 February 2018

Sophie Petropoulos

series ordinal

2

1 reference

12 February 2018

William Gibb

series ordinal

3

1 reference

12 February 2018

Stephen G Matthews

series ordinal

4

1 reference

12 February 2018

publication date

1 April 2012

1 reference

12 February 2018

published in

Reproductive Sciences

1 reference

12 February 2018

volume

19

1 reference

12 February 2018

issue

4

1 reference

12 February 2018

page(s)

407-415

1 reference

12 February 2018

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Biochemistry of multidrug resistance mediated by the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Sites of mRNA expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes in the human placenta of early pregnancy: No evidence for complementary expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Corticosteroid regulation of P-glycoprotein in the developing blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

P-glycoprotein: from genomics to mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Inhibition of P-glycoprotein by newer antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Cohort study of depressed mood during pregnancy and after childbirth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Developmental expression of multidrug resistance phosphoglycoprotein (P-gp) in the mouse fetal brain and glucocorticoid regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Rapid DNA extraction and PCR-sexing of mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Fluoxetine and reversal of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Drug-drug interactions involving antidepressants: focus on venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Tissue-specific regulation of expression and activity of P-glycoprotein in adjuvant arthritis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Safety of selective serotonin reuptake inhibitors in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1933719111424438

21 January 2018

Identifiers

DOI

10.1177/1933719111424438

1 reference

12 February 2018

1 reference

12 February 2018